EastWest Bioscience Inc.
HBOSF · OTC
7/31/2021 | 7/31/2020 | 7/31/2019 | |
|---|---|---|---|
| Market Cap | $2 | $2 | $1 |
| - Cash | $1 | $0 | $0 |
| + Debt | $2 | $2 | $2 |
| Enterprise Value | $3 | $4 | $3 |
| Revenue | $1 | $1 | $1 |
| % Growth | -32% | -34% | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | 4.5% | 11% | 25.5% |
| EBITDA | -$2 | -$2 | -$3 |
| % Margin | -262.9% | -187.6% | -224.4% |
| Net Income | -$2 | -$1 | -$4 |
| % Margin | -256.2% | -122.7% | -262.5% |
| EPS Diluted | -0.017 | -0.014 | -0.046 |
| % Growth | -25.7% | 70.8% | – |
| Operating Cash Flow | -$1 | -$0 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$0 | -$2 |